Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Composition and variation of respiratory microbiota in healthy military personnel.

Hang J, Zavaljevski N, Yang Y, Desai V, Ruck RC, Macareo LR, Jarman RG, Reifman J, Kuschner RA, Keiser PB.

PLoS One. 2017 Dec 7;12(12):e0188461. doi: 10.1371/journal.pone.0188461. eCollection 2017.

2.

Adenovirus type 4 respiratory infections with a concurrent outbreak of coxsackievirus A21 among United States Army Basic Trainees, a retrospective viral etiology study using next-generation sequencing.

Hang J, Vento TJ, Norby EA, Jarman RG, Keiser PB, Kuschner RA, Binn LN.

J Med Virol. 2017 Aug;89(8):1387-1394. doi: 10.1002/jmv.24792. Epub 2017 Mar 3.

PMID:
28198541
3.

Frequency of influenza H3N2 intra-subtype reassortment: attributes and implications of reassortant spread.

Maljkovic Berry I, Melendrez MC, Li T, Hawksworth AW, Brice GT, Blair PJ, Halsey ES, Williams M, Fernandez S, Yoon IK, Edwards LD, Kuschner R, Lin X, Thomas SJ, Jarman RG.

BMC Biol. 2016 Dec 29;14(1):117. doi: 10.1186/s12915-016-0337-3.

4.

Genome Sequence of Bellavista Virus, a Novel Orthobunyavirus Isolated from a Pool of Mosquitoes Captured near Iquitos, Peru.

Hang J, Yang Y, Kuschner RA, Evangelista J, Astete H, Halsey ES, Kochel TJ, Forshey BM.

Genome Announc. 2016 Nov 10;4(6). pii: e01262-16. doi: 10.1128/genomeA.01262-16.

5.

Aspirin and Acute Respiratory Distress Syndrome.

Kuschner RA.

JAMA. 2016 Sep 27;316(12):1317-8. doi: 10.1001/jama.2016.12322. No abstract available.

PMID:
27673312
6.

Molecular Epidemiology of Adenovirus Type 21 Respiratory Strains Isolated From US Military Trainees (1996-2014).

Kajon AE, Hang J, Hawksworth A, Metzgar D, Hage E, Hansen CJ, Kuschner RA, Blair P, Russell KL, Jarman RG.

J Infect Dis. 2015 Sep 15;212(6):871-80. doi: 10.1093/infdis/jiv141. Epub 2015 Mar 6.

PMID:
25748322
7.

16S rRNA gene pyrosequencing of reference and clinical samples and investigation of the temperature stability of microbiome profiles.

Hang J, Desai V, Zavaljevski N, Yang Y, Lin X, Satya RV, Martinez LJ, Blaylock JM, Jarman RG, Thomas SJ, Kuschner RA.

Microbiome. 2014 Sep 16;2:31. doi: 10.1186/2049-2618-2-31. eCollection 2014.

8.

Genomic characterization of group C Orthobunyavirus reference strains and recent South American clinical isolates.

Hang J, Forshey BM, Yang Y, Solórzano VF, Kuschner RA, Halsey ES, Jarman RG, Kochel TJ.

PLoS One. 2014 Mar 14;9(3):e92114. doi: 10.1371/journal.pone.0092114. eCollection 2014.

9.

Adenovirus type 4 and 7 vaccination or adenovirus type 4 respiratory infection elicits minimal cross-reactive antibody responses to nonhuman adenovirus vaccine vectors.

Paris R, Kuschner RA, Binn L, Thomas SJ, Colloca S, Nicosia A, Cortese R, Bailer RT, Sullivan N, Koup RA.

Clin Vaccine Immunol. 2014 May;21(5):783-6. doi: 10.1128/CVI.00011-14. Epub 2014 Mar 12.

10.

A phase 3, randomized, double-blind, placebo-controlled study of the safety and efficacy of the live, oral adenovirus type 4 and type 7 vaccine, in U.S. military recruits.

Kuschner RA, Russell KL, Abuja M, Bauer KM, Faix DJ, Hait H, Henrick J, Jacobs M, Liss A, Lynch JA, Liu Q, Lyons AG, Malik M, Moon JE, Stubbs J, Sun W, Tang D, Towle AC, Walsh DS, Wilkerson D; Adenovirus Vaccine Efficacy Trial Consortium.

Vaccine. 2013 Jun 19;31(28):2963-71. doi: 10.1016/j.vaccine.2013.04.035. Epub 2013 Apr 25.

PMID:
23623865
11.

Enhanced de novo assembly of high throughput pyrosequencing data using whole genome mapping.

Onmus-Leone F, Hang J, Clifford RJ, Yang Y, Riley MC, Kuschner RA, Waterman PE, Lesho EP.

PLoS One. 2013 Apr 17;8(4):e61762. doi: 10.1371/journal.pone.0061762. Print 2013.

12.

Genome sequencing of pathogenic Rhodococcus spp.

Hang J, Clifford RJ, Yang Y, Riley MC, Mody RM, Kuschner RA, Lesho EP.

Emerg Infect Dis. 2012 Nov;18(11):1915-6. doi: 10.3201/eid1811.120818. No abstract available.

13.

Severe cavitary pneumonia caused by a non-equi Rhodococcus species in an immunocompetent patient.

Ng S, King CS, Hang J, Clifford R, Lesho EP, Kuschner RA, Cox ED, Stelsel R, Mody R.

Respir Care. 2013 Apr;58(4):e47-50. doi: 10.4187/respcare.02017. No abstract available.

14.

Quantitative predictions of binding free energy changes in drug-resistant influenza neuraminidase.

Ripoll DR, Khavrutskii IV, Chaudhury S, Liu J, Kuschner RA, Wallqvist A, Reifman J.

PLoS Comput Biol. 2012;8(8):e1002665. doi: 10.1371/journal.pcbi.1002665. Epub 2012 Aug 30.

15.

Complete genome sequence of Providencia stuartii clinical isolate MRSN 2154.

Clifford RJ, Hang J, Riley MC, Onmus-Leone F, Kuschner RA, Lesho EP, Waterman PE.

J Bacteriol. 2012 Jul;194(14):3736-7. doi: 10.1128/JB.00615-12.

16.

Random amplification and pyrosequencing for identification of novel viral genome sequences.

Hang J, Forshey BM, Kochel TJ, Li T, Solórzano VF, Halsey ES, Kuschner RA.

J Biomol Tech. 2012 Apr;23(1):4-10. doi: 10.7171/jbt.12-2301-001.

17.

Complete sequence of a novel 178-kilobase plasmid carrying bla(NDM-1) in a Providencia stuartii strain isolated in Afghanistan.

McGann P, Hang J, Clifford RJ, Yang Y, Kwak YI, Kuschner RA, Lesho EP, Waterman PE.

Antimicrob Agents Chemother. 2012 Apr;56(4):1673-9. doi: 10.1128/AAC.05604-11. Epub 2012 Jan 30.

18.

Emergent 2009 influenza A(H1N1) viruses containing HA D222N mutation associated with severe clinical outcomes in the Americas.

Houng HS, Garner J, Zhou Y, Lyons A, Kuschner R, Deye G, St Clair K, Douce RW, Chicaiza W, Blair PJ, Myers CA, Burke RL, Sanchez JL, Williams M, Halsey ES.

J Clin Virol. 2012 Jan;53(1):12-5. doi: 10.1016/j.jcv.2011.09.004. Epub 2011 Oct 28.

PMID:
22036040
19.

The addiction potential of hyperpalatable foods.

Gearhardt AN, Davis C, Kuschner R, Brownell KD.

Curr Drug Abuse Rev. 2011 Sep;4(3):140-5. Review.

PMID:
21999688
20.

Department of Defense influenza and other respiratory disease surveillance during the 2009 pandemic.

Burke RL, Vest KG, Eick AA, Sanchez JL, Johns MC, Pavlin JA, Jarman RG, Mothershead JL, Quintana M, Palys T, Cooper MJ, Guan J, Schnabel D, Waitumbi J, Wilma A, Daniels C, Brown ML, Tobias S, Kasper MR, Williams M, Tjaden JA, Oyofo B, Styles T, Blair PJ, Hawksworth A, Montgomery JM, Razuri H, Laguna-Torres A, Schoepp RJ, Norwood DA, Macintosh VH, Gibbons T, Gray GC, Blazes DL, Russell KL; AFHSC-GEIS Influenza Surveillance Writing Group, Rubenstein J, Hathaway K, Gibbons R, Yoon IK, Saunders D, Gaywee J, Stoner M, Timmermans A, Shrestha SK, Velasco JM, Alera MT, Tannitisupawong D, Myint KS, Pichyangkul S, Woods B, Jerke KH, Koenig MG, Byarugaba DK, Mangen FW, Assefa B, Williams M, Brice G, Mansour M, Pimentel G, Sebeny P, Talaat M, Saeed T, Espinosa B, Faix D, Maves R, Kochel T, Smith J, Guerrero A, Maupin G, Sjoberg P, Duffy M, Garner J, Canas L, Macias E, Kuschner RA, Shanks D, Lewis S, Nowak G, Ndip LM, Wolfe N, Saylors K.

BMC Public Health. 2011 Mar 4;11 Suppl 2:S6. doi: 10.1186/1471-2458-11-S2-S6. Review.

21.

Capacity-building efforts by the AFHSC-GEIS program.

Sanchez JL, Johns MC, Burke RL, Vest KG, Fukuda MM, Yoon IK, Lon C, Quintana M, Schnabel DC, Pimentel G, Mansour M, Tobias S, Montgomery JM, Gray GC, Saylors K, Ndip LM, Lewis S, Blair PJ, Sjoberg PA, Kuschner RA, Russell KL, Blazes DL; AFHSC-GEIS Capacity Building Writing Group, Witt CJ, Money NN, Gaydos JC, Pavlin JA, Gibbons RV, Jarman RG, Stoner M, Shrestha SK, Owens AB, Iioshi N, Osuna MA, Martin SK, Gordon SW, Bulimo WD, Waitumbi DJ, Assefa B, Tjaden JA, Earhart KC, Kasper MR, Brice GT, Rogers WO, Kochel T, Laguna-Torres VA, Garcia J, Baker W, Wolfe N, Tamoufe U, Djoko CF, Fair JN, Akoachere JF, Feighner B, Hawksworth A, Myers CA, Courtney WG, Macintosh VA, Gibbons T, Macias EA, Grogl M, O'Neil MT, Lyons AG, Houng HS, Rueda L, Mattero A, Sekonde E, Sang R, Sang W, Palys TJ, Jerke KH, Millard M, Erima B, Mimbe D, Byarugaba D, Wabwire-Mangen F, Shiau D, Wells N, Bacon D, Misinzo G, Kulanga C, Haverkamp G, Kohi YM, Brown ML, Klein TA, Meyers M, Schoepp RJ, Norwood DA, Cooper MJ, Maza JP, Reeves WE, Guan J.

BMC Public Health. 2011 Mar 4;11 Suppl 2:S4. doi: 10.1186/1471-2458-11-S2-S4. Review.

22.

Genome sequences of human adenovirus 14 isolates from mild respiratory cases and a fatal pneumonia, isolated during 2006-2007 epidemics in North America.

Houng HS, Gong H, Kajon AE, Jones MS, Kuschner RA, Lyons A, Lott L, Lin KH, Metzgar D.

Respir Res. 2010 Aug 25;11:116. doi: 10.1186/1465-9921-11-116.

23.

Incidence of leptospirosis in a select population in Nepal.

Myint KS, Murray CK, Scott RM, Shrestha MP, Mammen MP Jr, Shrestha SK, Kuschner RA, Joshi DM, Gibbons RV.

Trans R Soc Trop Med Hyg. 2010 Aug;104(8):551-5. doi: 10.1016/j.trstmh.2010.04.001. Epub 2010 May 21.

PMID:
20494385
24.

Multiplexed Luminex xMAP assay for detection and identification of five adenovirus serotypes associated with epidemics of respiratory disease in adults.

Washington C, Metzgar D, Hazbón MH, Binn L, Lyons A, Coward C, Kuschner R.

J Clin Microbiol. 2010 Jun;48(6):2217-22. doi: 10.1128/JCM.00029-10. Epub 2010 Apr 21.

25.

Adenovirus microsatellite reveals dynamics of transmission during a recent epidemic of human adenovirus serotype 14 infection.

Houng HS, Lott L, Gong H, Kuschner RA, Lynch JA, Metzgar D.

J Clin Microbiol. 2009 Jul;47(7):2243-8. doi: 10.1128/JCM.01659-08. Epub 2009 Apr 29.

26.

A double-blind, placebo-controlled study of the safety and immunogenicity of live, oral type 4 and type 7 adenovirus vaccines in adults.

Lyons A, Longfield J, Kuschner R, Straight T, Binn L, Seriwatana J, Reitstetter R, Froh IB, Craft D, McNabb K, Russell K, Metzgar D, Liss A, Sun X, Towle A, Sun W.

Vaccine. 2008 Jun 2;26(23):2890-8. doi: 10.1016/j.vaccine.2008.03.037. Epub 2008 Apr 10.

PMID:
18448211
27.

Characterization of monoclonal antibodies to hepatitis E virus (HEV) capsid protein and identification of binding activity.

He J, Kuschner RA, Dewar V, Voet P, Asher LV, Vaughn DW.

J Biomed Sci. 2007 Sep;14(5):555-63. Epub 2007 May 9.

PMID:
17487571
28.

Safety and efficacy of a recombinant hepatitis E vaccine.

Shrestha MP, Scott RM, Joshi DM, Mammen MP Jr, Thapa GB, Thapa N, Myint KS, Fourneau M, Kuschner RA, Shrestha SK, David MP, Seriwatana J, Vaughn DW, Safary A, Endy TP, Innis BL.

N Engl J Med. 2007 Mar 1;356(9):895-903.

29.

A Phase 2 study of a purified, inactivated virus vaccine to prevent Japanese encephalitis.

Lyons A, Kanesa-thasan N, Kuschner RA, Eckels KH, Putnak R, Sun W, Burge R, Towle AC, Wilson P, Tauber E, Vaughn DW.

Vaccine. 2007 Apr 30;25(17):3445-53. Epub 2007 Jan 4.

PMID:
17241714
30.

Hepatitis E antibody kinetics in Nepalese patients.

Myint KS, Endy TP, Shrestha MP, Shrestha SK, Vaughn DW, Innis BL, Gibbons RV, Kuschner RA, Seriwatana J, Scott RM.

Trans R Soc Trop Med Hyg. 2006 Oct;100(10):938-41. Epub 2006 Mar 15.

PMID:
16542692
31.

Evidence that rodents are a reservoir of hepatitis E virus for humans in Nepal.

He J, Innis BL, Shrestha MP, Clayson ET, Scott RM, Linthicum KJ, Musser GG, Gigliotti SC, Binn LN, Kuschner RA, Vaughn DW.

J Clin Microbiol. 2006 Mar;44(3):1208. No abstract available.

32.

Emergence of a new human adenovirus type 4 (Ad4) genotype: identification of a novel inverted terminal repeated (ITR) sequence from majority of Ad4 isolates from US military recruits.

Houng HS, Clavio S, Graham K, Kuschner R, Sun W, Russell KL, Binn LN.

J Clin Virol. 2006 Apr;35(4):381-7. Epub 2006 Jan 6.

PMID:
16406799
33.

Asthma and invasive pneumococcal disease.

Kuschner WG, Kuschner RA.

N Engl J Med. 2005 Aug 18;353(7):738-9; author reply 738-9. No abstract available.

PMID:
16108144
34.

Evidence that rodents are a reservoir of hepatitis E virus for humans in Nepal.

He J, Innis BL, Shrestha MP, Clayson ET, Scott RM, Linthicum KJ, Musser GG, Gigliotti SC, Binn LN, Kuschner RA, Vaughn DW.

J Clin Microbiol. 2002 Dec;40(12):4493-8. Retraction in: He J, Innis BL, Shrestha MP, Clayson ET, Scott RM, Linthicum KJ, Musser GG, Gigliotti SC, Binn LN, Kuschner RA, Vaughn DW. J Clin Microbiol. 2006 Mar;44(3):1208.

35.

TT virus infection in acute non-A to E hepatitis in northern Thailand.

Endy TP, Narupiti S, Myint KS, Suntayakorn S, Kuschner RA, Vaughn DW.

Southeast Asian J Trop Med Public Health. 2001 Dec;32(4):814-22.

PMID:
12041559
36.

Pre-exposure anti-Campylobacter jejuni immunoglobulin a levels associated with reduced risk of Campylobacter diarrhea in adults traveling to Thailand.

Walz SE, Baqar S, Beecham HJ, Echeverria P, Lebron C, McCarthy M, Kuschner R, Bowling S, Bourgeois AL, Scott DA.

Am J Trop Med Hyg. 2001 Nov;65(5):652-6.

PMID:
11716132
37.

Hepatitis E virus DNA vaccine elicits immunologic memory in mice.

He J, Hayes CG, Binn LN, Seriwatana J, Vaughn DW, Kuschner RA, Innis BL.

J Biomed Sci. 2001 Mar-Apr;8(2):223-6.

PMID:
11287754
38.

An accelerated schedule for tick-borne encephalitis vaccine: the American Military experience in Bosnia.

Craig SC, Pittman PR, Lewis TE, Rossi CA, Henchal EA, Kuschner RA, Martinez C, Kohlhase KF, Cuthie JC, Welch GE, Sanchez JL.

Am J Trop Med Hyg. 1999 Dec;61(6):874-8.

PMID:
10674662
39.

Deployed US Army soldiers' knowledge and use of personal protection measures to prevent arthropod-related casualties.

Gambel JM, Brundage JF, Kuschner RA, Kelley PW.

J Travel Med. 1998 Dec;5(4):217-20.

40.

Prophylaxis of Plasmodium falciparum malaria with azithromycin administered to volunteers.

Anderson SL, Berman J, Kuschner R, Wesche D, Magill A, Wellde B, Schneider I, Dunne M, Schuster BG.

Ann Intern Med. 1995 Nov 15;123(10):771-3.

PMID:
7574195
41.

In vitro effectiveness of azithromycin against doxycycline-resistant and -susceptible strains of Rickettsia tsutsugamushi, etiologic agent of scrub typhus.

Strickman D, Sheer T, Salata K, Hershey J, Dasch G, Kelly D, Kuschner R.

Antimicrob Agents Chemother. 1995 Nov;39(11):2406-10.

42.

Use of azithromycin for the treatment of Campylobacter enteritis in travelers to Thailand, an area where ciprofloxacin resistance is prevalent.

Kuschner RA, Trofa AF, Thomas RJ, Hoge CW, Pitarangsi C, Amato S, Olafson RP, Echeverria P, Sadoff JC, Taylor DN.

Clin Infect Dis. 1995 Sep;21(3):536-41.

PMID:
8527539
43.

Inflammatory cytokines produced in response to experimental human gonorrhea.

Ramsey KH, Schneider H, Cross AS, Boslego JW, Hoover DL, Staley TL, Kuschner RA, Deal CD.

J Infect Dis. 1995 Jul;172(1):186-91.

PMID:
7797909
44.

Experimental human gonococcal urethritis: 250 Neisseria gonorrhoeae MS11mkC are infective.

Schneider H, Cross AS, Kuschner RA, Taylor DN, Sadoff JC, Boslego JW, Deal CD.

J Infect Dis. 1995 Jul;172(1):180-5.

PMID:
7797908
45.

Activity of azithromycin as a blood schizonticide against rodent and human plasmodia in vivo.

Andersen SL, Ager A, McGreevy P, Schuster BG, Wesche D, Kuschner R, Ohrt C, Ellis W, Rossan R, Berman J.

Am J Trop Med Hyg. 1995 Feb;52(2):159-61.

PMID:
7872444
46.

Inflammatory cytokine response to experimental human infection with Neisseria gonorrhoeae.

Ramsey KH, Schneider H, Kuschner RA, Trofa AF, Cross AS, Deal CD.

Ann N Y Acad Sci. 1994 Aug 15;730:322-5. No abstract available.

PMID:
8080200
47.

Azithromycin prophylaxis against a chloroquine-resistant strain of Plasmodium falciparum.

Kuschner RA, Heppner DG, Andersen SL, Wellde BT, Hall T, Schneider I, Ballou WR, Foulds G, Sadoff JC, Schuster B, et al.

Lancet. 1994 Jun 4;343(8910):1396-7. Erratum in: Lancet 1994 Jul 2;344(8914):69.

PMID:
7910886
48.

Safety and immunogenicity of the oral, whole cell/recombinant B subunit cholera vaccine in North American volunteers.

Sanchez JL, Trofa AF, Taylor DN, Kuschner RA, DeFraites RF, Craig SC, Rao MR, Clemens JD, Svennerholm AM, Sadoff JC, et al.

J Infect Dis. 1993 Jun;167(6):1446-9.

PMID:
8501336

Supplemental Content

Loading ...
Support Center